The Investment 'Business With Disease'
This presentation was given by Chris Fairhurst to
The Hague Tribunal, 14th June 2003
Good Afternoon Ladies and Gentlemen. My witness statement this afternoon
concerns the dubious business practices of a global industry – specifically,
the pharmaceutical industry – and the financial interest groups
supporting it. I shall refer collectively to this industry and its financiers
throughout my testimony as the ‘Business With Disease’ for
reasons that will already be obvious.
In the world of the ‘business with disease’ profit and the
accumulation of wealth is the main driving force behind every decision
taken. To the men who control these companies, it isn’t important
how the profits (and hence the wealth) are generated, simply that they
Some of the biggest companies in the world make vast profits from businesses
as diverse as computer software, retailing, insurance, oil – even
your health. More accurately perhaps I should say, your ill health.
In the world of the ‘business with disease’ - and there
is no bigger business in the world than the pharmaceutical industry – your
well being does not make healthy profits for shareholders. However, your
ill health does.
Consider the following evidence: the ‘business with disease’ makes
more profit than any other industry on earth. In fact, it makes more
profit than the automobile, chemical and airline industries combined.
And these profits are made at the expense of your health.
A Brief History of the Development of the Pharmaceutical Industry
To explain why this is so, it is necessary to briefly consider the historic
development of the ‘business with disease’
In the early part of the 20th century, a number of powerful and wealthy
individuals who owned or managed a significant proportion of the corporate
wealth of the United States, wealth that had been earned during the industrial
revolution of the latter part of the 19th century, recognized that the ‘industrialization’ of
health care would offer them further opportunities to control even more
wealth and power.
By ‘rationalizing’ (as they described it) the provision
of public health care and incorporating into this process the technological
developments taking place in chemistry in the early 20th century, these
men developed health care as a business – a business that would
eventually lead to the patent based pharmaceutical industry of today.
The vast wealth of these men made it possible for them to set up and
refine institutions and later companies that would guarantee them total
control of the machinery of public health provision.
By continuously refining (and funding) these operations throughout the
first half of the 20th century, these men were able to develop the business
model of the pharmaceutical industry that we know today – a model
that consists of the financial exploitation of patent rights over technologically
produced and synthetically manufactured drugs.
The most prominent of these individuals was an American called John
D Rockefeller. A detailed history of his drive to create an industrialized
health care system can be read on the website of the Dr Rath Health Foundation.
The book describing how this man rigorously applied his undoubted business
talents to the creation of a new industry to further his already massive
wealth and power is called ‘Rockefeller Medicine Men’ and
you will find it on the ‘History
of the ‘Business With Disease’ page of the Foundation
Rockefeller liked people to think of him as a philanthropist, someone
who used his vast wealth for the benefit of mankind but, in fact, he
was probably one of the most ruthless and determinedly avaricious men
Rockefeller’s Standard Oil Company dominated the oil industry
throughout the early years of the 20th century and most of today’s
major oil companies such as ExxonMobil and Esso are direct descendants
of Standard Oil.
I shall return to this connection later.
Rockefeller’s business associates included the banker J P Morgan,
the US representative for the Rothschild banking family and the Bank
of England. Together, these two men helped to create the Federal Reserve
Board of the United States, an institution that regulates all financial
dealings in that country and which still exists today.
You may be familiar with the name J P Morgan through the current banking
group J P Morgan Chase. The Chase part of this name comes from Chase
Bank, owned by the Rockefeller family, demonstrating that these early
associations have been maintained and survive to this day. I shall return
to examine the J P Morgan Chase company later in this statement.
At this point in my statement, it is appropriate to consider the following
The Rockefeller family, through Chase Bank and the Standard Oil Company,
together with J P Morgan through the Morgan Bank, were major financial
supporters of Nazi Germany’s Third Reich. In fact Standard Oil
was the largest shareholder in IG Farben and IG Farben was, next to the
Rockefeller family, the largest shareholder in Standard Oil.
Through this relationship, and many others like it, the industrialized
model of public healthcare was to gain a stranglehold in every developed
country of the world. By investing heavily in medical research, doctors
training, the manufacture and supply of medicines and public health policy,
the patient-centered community systems that had gone before and that
treated the patient as an individual were gradually swallowed up or abolished.
The industrialized model favored by the Rockefeller Medicine Men treated
the patient as a customer and the medicines it produced as a commodity.
Everything was geared towards the sale of products – and if the
products happened to have side effects that created a market for more
products to be sold, then so much the better.
And this is still the business model being used today. Consider this
During the 5 year period from 1996 to 2000, the pharmaceutical industry’s
spending on the promotion of prescription drugs increased from $ 9.2
billion a year to $ 15.7 billion a year.
As a result of these business practices, the industrialized model of
public healthcare carries an inbuilt counter-incentive to the removal
of common diseases. To eliminate them would reduce the opportunities
to sell more medicines and thus to make more money from continued ill
This business model was refined and extended throughout the second
half of the 20th century to such an extent that the pharmaceutical industry
overtook the petrochemical industry to become the largest and most profitable
industry on earth.
Power and Wealth from Illness and Disease
This brief history of the development of the ‘business with disease’ sets
the scene for my critical analysis of how this business has been refined
up to the present day. For more detailed information about the history
of the ‘business with disease’ please visit the Dr Rath Health
Having illustrated the history of its development, I shall now examine
the current status of the ‘business with disease.’
As you can see from this table, more than a quarter of the 50 largest
companies in the world today are either pharmaceutical or petrochemical
companies. The Rockefeller business model obviously works. Please take
a moment to study the table.
Why are petrochemical companies included in this list? The previous
part of my statement may have provided some clues. Further explanation
will follow shortly.
For now, I shall continue to concentrate on the pharmaceutical industry.
The companies in this table are ranked in order of their market value
measured in billions of US dollars. Yes, ladies and gentleman of the
jury, you should add 6 zeros to the figures in the table to arrive at
the true values!
The only other industry that comes close to this level of wealth generation
is the world of international finance – banks, insurance companies
and investment management groups. I shall return again to this group
later in my statement. For now, I would just ask you to note that J P
Morgan Chase appear in this table at number 50.
At number three in the table is Pfizer Incorporated. I should now like
to take a closer look at their figures.
Pfizer is the largest of the pharmaceutical/petrochemical companies
and is currently valued at around 265 billion dollars.
The company owns the patent rights to 8 of the world’s top 25
selling synthetic drugs (such as Lipitor, Viagra, Diflucan and Zoloft
for example) and these patent rights enabled Pfizer to earn 32 billion
dollars in 2002 from sales of their products.
To put these figures into some perspective, Pfizer’s current market
value is greater than the wealth of several large and prosperous countries,
as measured by the World Bank.
Returning to the table, at number 4 is ExxonMobil, the world’s
largest petrochemical company. I referred to this company earlier in
my statement. It is a direct descendant of the Rockefeller owned Standard
Oil Company and this connection is the reason why petrochemical companies
are part of my analysis.
Please now consider Exxon’s financial position.
Once again, the figures are almost beyond comprehension.
You may wonder why Exxon has a slightly lower market value than Pfizer
when its income is more than 6 times greater.
The reason is that the petrochemicals business has higher operating
costs than pharmaceuticals – in simple terms, as we have already
seen, the pharmaceutical business is much more profitable.
An obvious question to pose at this point is: ‘who controls this
All global companies whose shares are traded on the world’s stock
exchanges have a Board of Directors who run the company on behalf of
the owners. The owners of the company are the shareholders. If you own
shares in any of the companies in the table, you are a part-owner of
However, your shareholdings are individually too small to give you many
ownership benefits. The major shareholders are the ones who have these
rights and who enjoy the vast wealth and influence this brings with it.
I should now like to carefully examine the directors and shareholders
of the two companies presently under consideration. Turning first to
Pfizer, upon investigation I found some key names on their Board of Directors,
I would ask you to pay particular attention to the other directorships
held by these men and which are highlighted in the exhibit and to remember
these as I move on to consider the board members of ExxonMobil.
The same pattern of interlinking directorships is again demonstrated
on Exxon’s board.
Since these people will meet regularly at Board meetings, on investment
committees and at shareholder meetings, I have therefore put them together
as a group.
This group, who control the daily operations of two of the largest companies
in the world, not only sit on the boards of both companies, but also
on the board of one of the world’s largest investment institutions
- an institution that has enormous shareholdings in both pharmaceutical
and petrochemical companies – JP Morgan Chase.
Please remember that it is the shareholders who own the companies and
control the wealth so, if you are both a major shareholder and director
of any company, you have total control of that company.
Not only control over how the company makes its money but also what
it does with that money and who benefits from it. In the case of the ‘business
with disease’ these multi- trillion dollar financial benefits are
earned from the systematic promotion of diseases at the expense of good
I shall return to the mystery person in this group, after some further
At this point, it is appropriate to consider the role of J P Morgan
Chase in the ‘business with disease.’
The common thread here, apart from shared directorships is that, as
I mentioned a moment ago, J P Morgan Chase is a significant shareholder
of both pharmaceutical and petrochemical company shares.
Here is a sample of just some of J P Morgan Chases’ extensive
shareholdings. My research led me to question whether the same pattern
of common directorships could be repeated in these other companies, so
I next analysed Merck. Here are the results:
Merck & Co Incorporated, another pharmaceutical company, also has
2 directors who sit on the board of JP Morgan Chase, one of whom is not
only Chairman of J P Morgan Chase, but also a director of the New York
Could this be just coincidence? Highly unlikley. It is my opinion that
this demonstrates a definite structured approach to the control and ownership
of some of the largest companies in the world.
The Inner Circle group is now a little bigger. I have still not revealed
the identity of the mystery man because, first, it is necessary to examine
the company J P Morgan Chase again.
This time, I looked at the Advisory Board of the company. Investment
companies like J P Morgan Chase have advisory boards that control the
investment policy of the company – in other words, they decide
what type of companies to invest in and whose shares to buy.
The J P Morgan International Council is the most senior of their advisory
boards and upon examination of the members of this Council, the key figure,
the mystery man is finally revealed:
David Rockefeller, grandson of John D Rockefeller, creator and guiding
force of the ‘Business With Disease.’
JD’s grandson David is doing a fine job upholding the family traditions.
As owner and past chairman of the Chase Manhattan Bank (now part of JP
Morgan Chase) his wealth, power and influence extend way beyond oil,
pharmaceuticals and banking – still the powerhouse of Rockefeller
wealth – as is demonstrated by his other connections.
1x As founding father of The Trilateral Commission, David Rockefeller
has enjoyed unparalleled private access to the world’s political
and business leaders for nearly 30 years, providing the Rockefeller dynasty
with the opportunity to pursue its criminal ‘business with disease’ unopposed.
There is more information about the Rockefeller financed Trilateral Commission
on the Dr Rath Health Foundation website.
The family has managed to build and successfully maintain the ‘business
with disease’ for more than 60 years, through personal influence,
control of banks, ownership of pharmaceutical and petrochemical companies,
financial support for their favored politicians and a multitude of other
practices originally developed by the patriach John D Rockefeller,.
As my evidence shows, David Rockefeller continues the traditions.
These facts provide clear evidence of the criminal activities of the ‘business
with disease’ that are the subject of the charges being heard today.
That concludes my testimony for the prosecution.
In closing I would add that, by participating in ‘The Hague Tribunal’ you
are helping to initiate the process by which the ‘business with
disease’ will be finally dismantled and brought to justice. The
criminal acts of this industry can then be replaced by a health care
system that focuses on safe, effective, non-patentable and side effect
free natural therapies.
The dismantling of the Rockefeller inspired pharmaceutical business
model will lead to the collapse of the financial empire that is built
upon those illegal practices and thus to the release of massive funds
for re-investment into changes that will lead to future peace, good health
and social justice for us all.